Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin retreatment for incompletely recovered COPD exacerbations
2012-002198-72Phase 3Completed
- Sponsor
- Imperial College London
- Start
- Nov 2013
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ciprofloxacin in chronic obstructive pulmonary disease (COPD), sponsored by Imperial College London. Started Nov 2013; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2012-002198-72.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002198-72.